- Angiotensin Receptor Neprilysin Inhibitors in HFrEF: Is This the First Disease Modifying Therapy Drug Class Leading to a Substantial Reduction in Diuretic Need?
-
Kerr B, Pharithi RB, Barrett M, Halley C, Gallagher J, Ledwidge M, McDonald K
- KMID: 2532577
- Int J Heart Fail.
- 2021 Apr;3(2):106-116.
- doi: 10.36628/ijhf.2020.0043
Despite significant advances in disease modifying therapy in heart failure (HF), diuretics have remained the cornerstone of volume management in all HF phenotypes. Diuretics, alongside their definite acute haemodynamic and... -
- CITED
-
- Close
- SHARE
-
- Close
